Phosphoenix raises $1.3M Pre-seed (Netherlands, Sep 2026)
Reach the investors backing rounds like this
Backed by TTT Medtech Fund, FIRST Fund +2 more · verified emails and LinkedIn on Datapile
Amsterdam’s Phosphoenix raises €1.3 million to advance neuroprosthesis for profound blindness - EU-Startups
Phosphoenix is an Amsterdam-based MedTech startup developing a neuroprosthetic system for people with profound blindness. Their system uses a proprietary Fountain Probe with over 1,000 microelectrodes to directly stimulate the brain's visual pathway, bypassing damage to the eyes. This €1.3 million financing round will support preparations for their first-in-human clinical study and further development of their neurostimulation system.
Amsterdam’s Phosphoenix raises €1.3 million to advance neuroprosthesis for profound blindness EU-Startups
| Oct 08, 2026 | Innercrowd | $750K | — | Netherlands |
| Oct 06, 2026 | Hadrian | $38.6M | — | Netherlands |
| Sep 30, 2026 | Blue Health Intelligence | $3.6M | — | Netherlands |
| Sep 24, 2026 | Duqu | $1.5M | Pre-seed | Netherlands |
7,193 investors back startups in Netherlands
You just read who funded Phosphoenix. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 15 investor contact unlocks a month, no card required.